Announcements Trials
Browse Landscape

Status

Completed 2Unknown 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 1872Neoplasms 1257Colorectal Neoplasms 1059Carcinoma, Non-Small-Cell Lung 1012Stomach Neoplasms 803Carcinoma, Hepatocellular 785Lung Neoplasms 769Prostatic Neoplasms 697Pancreatic Neoplasms 577Rectal Neoplasms 450Ovarian Neoplasms 406Neoplasm Metastasis 405Colonic Neoplasms 405Uterine Cervical Neoplasms 400Recurrence 383Leukemia, Myeloid, Acute 372Esophageal Neoplasms 363Multiple Myeloma 340Lymphoma 335Head and Neck Neoplasms 330Melanoma 312Precursor Cell Lymphoblastic Leukemia-Lymphoma 292Brain Neoplasms 264Urinary Bladder Neoplasms 256Liver Neoplasms 225Nasopharyngeal Carcinoma 223Leukemia 218Lymphoma, Large B-Cell, Diffuse 216Polycystic Ovary Syndrome 210Squamous Cell Carcinoma of Head and Neck 205

Interventions

Toremifene 1Tamoxifen 1Ovariectomy 1Gonadotropin-Releasing Hormone 1Aromatase Inhibitors 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Hormone-receptor-positive Breast Cancer × Clear all
NCT05801705 2023-05-18

Comparative Evaluation of Efficacy and Safety of Toremifene, Tamoxifen, and Aromatase Inhibitor Plus Ovarian Function Suppression in Hormone Receptor-Positive Early Breast Cancer Among Non-Low-Risk Premenopausal Women: A Real-World Study

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Unknown
700 enrolled
Breast

Hormone-receptor-positive Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡